Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Sanyal

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|December 17, 2003
Stamping out cancerU Sanyal
Neoplasma|December 29, 1999
Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agentsM Ghosh, S Dutta, U Sanyal
Neoplasma|January 1, 1995
Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimideU Sanyal, S Dutta, H Das
International Journal of Cancer|March 16, 1995
Purification and characterization of a new 85-kDa glycoprotein antigen from human breast tumorS Pal, U Sanyal, U Chattopadhyay
Journal of Experimental & Clinical Cancer Research : CR|March 28, 2008
Evaluation of dimethoxydop-NU as a novel anti-tumor agentA Mukherjee, S Dutta, U Sanyal
Neoplasma|January 1, 1993
Vitamin E--its status and role in leukemia and lymphomaJ Dasgupta, U Sanyal, S Das
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 17, 2001
Model for the generation of toroidal and poloidal magnetic fields in a laser-produced plasmaB Bhattacharyya, U Sanyal, S V Lawande
Neoplasma|January 1, 1983
New arylsulfonylhydrazones of substituted benzaldehydes as anticancer agentsP Pal, U Sanyal, S K Chakraborti
Journal of Experimental & Clinical Cancer Research : CR|June 20, 2002
Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agentS Samanta, A Pain, S Dutta, et al.
Neoplasma|January 1, 1994
Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in miceS Bhattacharya, C Ganguly, U Sanyal, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|December 17, 2003
Stamping out cancerU Sanyal
Neoplasma|December 29, 1999
Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agentsM Ghosh, S Dutta, U Sanyal
Neoplasma|January 1, 1995
Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimideU Sanyal, S Dutta, H Das
International Journal of Cancer|March 16, 1995
Purification and characterization of a new 85-kDa glycoprotein antigen from human breast tumorS Pal, U Sanyal, U Chattopadhyay
Journal of Experimental & Clinical Cancer Research : CR|March 28, 2008
Evaluation of dimethoxydop-NU as a novel anti-tumor agentA Mukherjee, S Dutta, U Sanyal
Neoplasma|January 1, 1993
Vitamin E--its status and role in leukemia and lymphomaJ Dasgupta, U Sanyal, S Das
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 17, 2001
Model for the generation of toroidal and poloidal magnetic fields in a laser-produced plasmaB Bhattacharyya, U Sanyal, S V Lawande
Neoplasma|January 1, 1983
New arylsulfonylhydrazones of substituted benzaldehydes as anticancer agentsP Pal, U Sanyal, S K Chakraborti
Journal of Experimental & Clinical Cancer Research : CR|June 20, 2002
Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agentS Samanta, A Pain, S Dutta, et al.
Neoplasma|January 1, 1994
Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in miceS Bhattacharya, C Ganguly, U Sanyal, et al.
Pageof 3